Aarey Drugs & Pharmaceuticals Ltd. Hits Upper Circuit on BSE, 27 October 2026

Trading it today means dealing with a book where almost everyone wants to buy, which is the plain meaning of the Aarey Drugs & Pharmaceuticals upper circuit. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) was locked at Rs 106.7 on BSE on 27 October 2026, up 4.97% from the previous close of Rs 101.65, with a market cap of Rs 324 crore.

Buying interest met the exchange-defined price band, and the stock was pinned at that limit when this was written.

Key Takeaways

• Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) hit the upper circuit on BSE at Rs 106.7 on 27 October 2026.
• The session move was +4.97% against a previous close of Rs 101.65.
• Market capitalisation stood at Rs 324 crore with a PE ratio of 77.59.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Aarey Drugs & Pharmaceuticals Ltd.
Current Price / LTP	Rs 106.7
Day Move	4.97%
Previous Close	Rs 101.65
Day Open	Rs 102.3
Day High	Rs 106.7
Day Low	Rs 102.25
Upper Circuit Price	Rs 106.7
Upper Circuit Limit	Rs 106.7
Market Cap	Rs 324 crore
Selected Exchange	BSE
PE Ratio	77.59

All figures above are as of 27 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

The stock opened at Rs 102.3 on BSE, a touch above the previous close of Rs 101.65. It traded as low as Rs 102.25 and then rose to Rs 106.7, which is the upper circuit price for the session.

Most of the distance was covered between the low of Rs 102.25 and the band at Rs 106.7. The gain over the previous close was Rs 5.05, or 4.97%. All figures come from BSE alone, because price bands, day ranges and previous-close values can differ between exchanges. The band limit of Rs 106.7 is the level the price reached.

Why Aarey Drugs & Pharmaceuticals Ltd. Hit Upper Circuit

Aarey Drugs & Pharmaceuticals Ltd. hit the upper circuit after buying interest pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.

Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.

Within the session the stock reached the upper circuit level of Rs 106.7.

What the Aarey Drugs & Pharmaceuticals Upper Circuit Means

An upper circuit is the highest price the exchange band lets a stock touch in one session. For Aarey Drugs & Pharmaceuticals Ltd., that limit was recorded at Rs 106.7 on 27 October 2026.

Bands are built to soften extreme swings and keep trading orderly. They describe how the market is structured and give no view on future returns. Here the circuit simply marks how the session unfolded and where the band stopped the price.

Aarey Drugs & Pharmaceuticals Ltd. Fundamentals and Valuation

Available market data gives a fuller picture than price action alone. For Aarey Drugs & Pharmaceuticals Ltd., PE ratio was 77.59, PB ratio was 1.91, book value was Rs 53.35, EPS was 1.31, ROE was 2.81%, ROCE was 5.57%, dividend yield was 0% and debt-to-assets ratio was 0.34, on a market cap of Rs 324 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.

At the reported PB ratio of 1.91, the market valued Aarey Drugs & Pharmaceuticals Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.

For investors tracking upper circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.

Peer and Sector Context

Aarey Drugs & Pharmaceuticals Ltd. belongs to the Trading industry. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
Confidence Petroleum India Ltd.	Rs 2319.04 crore	17.23	1.58	7%
Vintage Coffee & Beverages Ltd.	Rs 2165.1 crore	27.49	3.85	17.91%
Aayush Art And Bullion Ltd.	Rs 2007.81 crore	254.42	33.03	13.89%
Fischer Medical Ventures Ltd.	Rs 1889.25 crore	63.35	4.06	9.38%
Khazanchi Jewellers Ltd.	Rs 1742.43 crore	17.07	5.02	32.45%

Several of these peers are far larger by market capitalisation than Aarey Drugs & Pharmaceuticals Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Aarey Drugs & Pharmaceuticals Ltd.'s PE ratio was 77.59, compared with an available peer PE average of 75.91, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 54.83, the 50-day moving average was 104.65 and the 200-day moving average was 89.15.

What Readers Should Know

The confirmed fact is that Aarey Drugs & Pharmaceuticals Ltd. reached the upper circuit on BSE at Rs 106.7 on 27 October 2026, a 4.97% day move.

With so many buyers at the band, execution is the practical difficulty: sellers are scarce, and the quoted price may not be one at which an order fills. No official catalyst had been confirmed at the time of writing, either.

Upper circuit sessions serve as market updates more than as complete conclusions. Interest at the band is evident, but anything deeper should weigh business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Aarey Drugs & Pharmaceuticals Ltd. hit upper circuit on 27 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was AAREYDRUGS share price on 27 October 2026?

The last traded price used in this article was Rs 106.7 on BSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for AAREYDRUGS?

The upper circuit price was Rs 106.7. The stated exchange upper circuit limit was Rs 106.7. The event numbers in this article are aligned to BSE.

What is Aarey Drugs & Pharmaceuticals Ltd.'s market cap and PE ratio?

Aarey Drugs & Pharmaceuticals Ltd.'s market cap was Rs 324 crore. PE ratio was 77.59.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 27 October 2026.

Does hitting an upper circuit mean Aarey Drugs & Pharmaceuticals Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Aarey Drugs & Pharmaceuticals Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Aarey Drugs & Pharmaceuticals Ltd. the stated limit was Rs 106.7. For this session, Aarey Drugs & Pharmaceuticals Ltd. moved 4.97%.